Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1545

1.

Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.

Neilsen BK, Sleightholm R, McComb R, Ramkissoon SH, Ross JS, Corona RJ, Miller VA, Cooke M, Aizenberg MR.

J Neurooncol. 2018 Dec 9. doi: 10.1007/s11060-018-03070-2. [Epub ahead of print]

PMID:
30535594
2.

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors.

Sigal DS, Bhangoo MS, Hermel JA, Pavlick DC, Frampton G, Miller VA, Ross JS, Ali SM.

Oncotarget. 2018 Nov 9;9(88):35809-35812. doi: 10.18632/oncotarget.26260. eCollection 2018 Nov 9.

3.

Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic HBV.

Anderson RT, Lim SG, Mishra P, Josephson F, Donaldson E, Given B, Miller V.

Gastroenterology. 2018 Dec 4. pii: S0016-5085(18)35378-2. doi: 10.1053/j.gastro.2018.11.062. [Epub ahead of print] No abstract available.

PMID:
30529300
4.

Approach to evaluating tumor mutational burden in routine clinical practice.

Truesdell J, Miller VA, Fabrizio D.

Transl Lung Cancer Res. 2018 Dec;7(6):678-681. doi: 10.21037/tlcr.2018.10.10. Review.

5.

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.

Goldberg ME, Montesion M, Young L, Suh J, Greenbowe J, Kennedy M, Giaccone G, Akerley WL, Dowlati A, Creelan BC, Hicks JK, Hesketh PJ, Kelly KL, Riess JW, Miller VA, Stephens PJ, Frampton GM, Ali S, Gregg JP, Albacker LA.

PLoS One. 2018 Nov 27;13(11):e0208097. doi: 10.1371/journal.pone.0208097. eCollection 2018.

6.

Investigating Barriers to Family Visitation of Nursing Home Residents: A Systematic Review.

Miller VJ.

J Gerontol Soc Work. 2018 Nov 9:1-18. doi: 10.1080/01634372.2018.1544957. [Epub ahead of print]

PMID:
30412036
7.

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.

Zhou C, Yuan Z, Ma W, Qi L, Mahavongtrakul A, Li Y, Li H, Gong J, Fan RR, Li J, Molmen M, Clark TA, Pavlick D, Frampton GM, Forcier B, Moore EH, Shelton DK, Cooke M, Ali SM, Miller VA, Gregg JP, Stephens PJ, Li T.

J Hematol Oncol. 2018 Nov 6;11(1):129. doi: 10.1186/s13045-018-0671-8.

8.

Involving Youth With a Chronic Illness in Decision-making: Highlighting the Role of Providers.

Miller VA.

Pediatrics. 2018 Nov;142(Suppl 3):S142-S148. doi: 10.1542/peds.2018-0516D.

PMID:
30385620
9.

Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.

Kang H, Pettinga D, Schubert AD, Ladenson PW, Ball DW, Chung JH, Schrock AB, Madison R, Frampton GM, Stephens PJ, Ross JS, Miller VA, Ali SM.

Oncologist. 2018 Oct 29. pii: theoncologist.2018-0334. doi: 10.1634/theoncologist.2018-0334. [Epub ahead of print]

PMID:
30373905
10.

Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung Cancer.

Schrock AB, Welsh A, Chung JH, Pavlick D, Bernicker EH, Creelan BC, Forcier B, Ross JS, Stephens PJ, Ali SM, Dagogo-Jack I, Shaw AT, Li T, Ou SI, Miller VA.

J Thorac Oncol. 2018 Oct 24. pii: S1556-0864(18)33205-2. doi: 10.1016/j.jtho.2018.10.008. [Epub ahead of print]

11.

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer.

Ruder D, Papadimitrakopoulou V, Shien K, Behrens C, Kalhor N, Chen H, Shen L, Lee JJ, Hong WK, Tang X, Girard L, Minna JD, Diao L, Wang J, Mino B, Villalobos P, Rodriguez-Canales J, Hanson NE, Sun J, Miller V, Greenbowe J, Frampton G, Herbst RS, Baladandayuthapani V, Wistuba II, Izzo JG.

Oncotarget. 2018 Sep 21;9(74):33995-34008. doi: 10.18632/oncotarget.26129. eCollection 2018 Sep 21.

12.

Evidenced-Based Interventions for Children With Autism Spectrum Disorder.

Will MN, Currans K, Smith J, Weber S, Duncan A, Burton J, Kroeger-Geoppinger K, Miller V, Stone M, Mays L, Luebrecht A, Heeman A, Erickson C, Anixt J.

Curr Probl Pediatr Adolesc Health Care. 2018 Oct;48(10):234-249. doi: 10.1016/j.cppeds.2018.08.014. Epub 2018 Oct 15.

PMID:
30337149
13.

Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.

Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K.

JAMA Neurol. 2018 Oct 15. doi: 10.1001/jamaneurol.2018.3057. [Epub ahead of print]

PMID:
30326011
14.

Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer.

Croessmann S, Formisano L, Kinch LN, Gonzalez-Ericsson PI, Sudhan DR, Nagy RJ, Mathew A, Bernicker EH, Cristofanilli M, He J, Cutler RE Jr, Lalani AS, Miller VA, Lanman RB, Grishin NV, Arteaga CL.

Clin Cancer Res. 2018 Oct 12. doi: 10.1158/1078-0432.CCR-18-1544. [Epub ahead of print]

PMID:
30314968
15.

Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study.

Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Mielke MM, Kantarci K, Miller VM.

Maturitas. 2018 Nov;117:64-77. doi: 10.1016/j.maturitas.2018.09.002. Epub 2018 Sep 14.

PMID:
30314564
16.

ClinGen's GenomeConnect registry enables patient-centered data sharing.

Savatt JM, Azzariti DR, Faucett WA, Harrison S, Hart J, Kattman B, Landrum MJ, Ledbetter DH, Miller VR, Palen E, Rehm HL, Rhode J, Turner S, Vidal JA, Wain KE, Riggs ER, Martin CL.

Hum Mutat. 2018 Nov;39(11):1668-1676. doi: 10.1002/humu.23633.

PMID:
30311371
17.

Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging.

Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, LeBrasseur NK, Schafer MJ, Mielke MM, Kantarci K, Stewart EA, Miller VM.

Physiology (Bethesda). 2018 Nov 1;33(6):374-383. doi: 10.1152/physiol.00024.2018.

PMID:
30303778
18.

Characteristics Associated With High-Impact Pain in People With Temporomandibular Disorder: A Cross-Sectional Study.

Miller VE, Poole C, Golightly Y, Barrett D, Chen DG, Ohrbach R, Greenspan JD, Fillingim RB, Slade GD.

J Pain. 2018 Oct 4. pii: S1526-5900(18)30665-5. doi: 10.1016/j.jpain.2018.09.007. [Epub ahead of print]

PMID:
30292793
19.

Comparative Genomic Profiling of Refractory/Metastatic Penile and non-Penile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.

Jacob JM, Ferry EK, Gay LM, Elvin JA, Vergilio J, Ramkissoon S, Severson E, Necchi A, Killian JK, Ali SM, Schrock AB, Liu NW, Chung J, Miller VA, Stephens PJ, Welsh A, Corona RJ, Ross JS, Bratslavsky G.

J Urol. 2018 Oct 3. pii: S0022-5347(18)43962-6. doi: 10.1016/j.juro.2018.09.056. [Epub ahead of print]

PMID:
30291913
20.

Carving out another slice of the pie: Exceptional response to single agent imatinib in an asian female never-smoker with advanced NSCLC with a de-novo PDGFR-α N848 K mutation.

Klempner SJ, Gowen K, Lee TK, Zhu VW, Schrock AB, Miller VA, Ali SM, Ou SI.

Lung Cancer. 2018 Oct;124:86-89. doi: 10.1016/j.lungcan.2018.07.043. Epub 2018 Jul 31.

21.

Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.

Qin A, Johnson A, Ross JS, Miller VA, Ali SM, Schrock AB, Gadgeel SM.

J Thorac Oncol. 2018 Sep 26. pii: S1556-0864(18)33126-5. doi: 10.1016/j.jtho.2018.09.014. [Epub ahead of print]

PMID:
30267839
22.

Use of cold atmospheric pressure plasma to treat warts: a potential therapeutic option.

Friedman PC, Miller V, Fridman G, Fridman A.

Clin Exp Dermatol. 2018 Sep 27. doi: 10.1111/ced.13790. [Epub ahead of print] No abstract available.

PMID:
30264440
23.

PubMed Labs: an experimental system for improving biomedical literature search.

Fiorini N, Canese K, Bryzgunov R, Radetska I, Gindulyte A, Latterner M, Miller V, Osipov M, Kholodov M, Starchenko G, Kireev E, Lu Z.

Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay094.

24.

Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors.

Lin AG, Xiang B, Merlino DJ, Baybutt TR, Sahu J, Fridman A, Snook AE, Miller V.

Oncoimmunology. 2018 Jul 26;7(9):e1484978. doi: 10.1080/2162402X.2018.1484978. eCollection 2018.

PMID:
30228954
25.

Choosing a Nursing Home.

Miller VJ.

J Gerontol Soc Work. 2018 Sep 11:1-3. doi: 10.1080/01634372.2018.1515799. [Epub ahead of print] No abstract available.

PMID:
30204566
26.

Genomic Landscape of Adult and Pediatric BCR-ABL1-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing.

Severson EA, Vergilio JA, Gay LM, Daniel S, Hemmerich AC, Elvin JA, Britt N, Nahas M, Cohen MB, Brown C, Sathyan P, Rankin A, Miller V, Ross JS, Ramkissoon SH.

Oncologist. 2018 Sep 4. pii: theoncologist.2018-0272. doi: 10.1634/theoncologist.2018-0272. [Epub ahead of print]

PMID:
30181314
27.

Best Match: New relevance search for PubMed.

Fiorini N, Canese K, Starchenko G, Kireev E, Kim W, Miller V, Osipov M, Kholodov M, Ismagilov R, Mohan S, Ostell J, Lu Z.

PLoS Biol. 2018 Aug 28;16(8):e2005343. doi: 10.1371/journal.pbio.2005343. eCollection 2018 Aug.

28.

Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.

Fabrizio DA, George TJ Jr, Dunne RF, Frampton G, Sun J, Gowen K, Kennedy M, Greenbowe J, Schrock AB, Hezel AF, Ross JS, Stephens PJ, Ali SM, Miller VA, Fakih M, Klempner SJ.

J Gastrointest Oncol. 2018 Aug;9(4):610-617. doi: 10.21037/jgo.2018.05.06.

29.

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum.

Clin Infect Dis. 2018 Aug 22. doi: 10.1093/cid/ciy696. [Epub ahead of print]

PMID:
30137245
30.

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.

Liang WS, Vergilio JA, Salhia B, Huang HJ, Oki Y, Garrido-Laguna I, Park H, Westin JR, Meric-Bernstam F, Fabrizio D, Miller VA, Stephens PJ, Fanale MA, Ross JS, Janku F.

Oncologist. 2018 Aug 14. pii: theoncologist.2018-0058. doi: 10.1634/theoncologist.2018-0058. [Epub ahead of print]

PMID:
30108156
31.

A pilot study of observed physician-parent-child communication and child satisfaction in a gastroenterology clinic.

Becker TD, Lin HC, Miller VA.

Patient Prefer Adherence. 2018 Jul 26;12:1327-1335. doi: 10.2147/PPA.S171620. eCollection 2018.

32.

Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains.

Palacios M, Miner TA, Frederick DR, Sepulveda VE, Quinn JD, Walker KA, Miller VL.

MBio. 2018 Aug 7;9(4). pii: e01443-18. doi: 10.1128/mBio.01443-18.

33.

Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies.

Greenplate A, Wang K, Tripathi RM, Palma N, Ali SM, Stephens PJ, Miller VA, Shyr Y, Guo Y, Reddy NM, Kozhaya L, Unutmaz D, Chen X, Irish JM, Davé UP.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00019. Epub 2018 Feb 13.

PMID:
30079384
34.

Sex-Specific Physiology and Cardiovascular Disease.

Shufelt CL, Pacheco C, Tweet MS, Miller VM.

Adv Exp Med Biol. 2018;1065:433-454. doi: 10.1007/978-3-319-77932-4_27.

PMID:
30051400
35.

The hepatitis B epidemic and the urgent need for cure preparedness.

Lazarus JV, Block T, Bréchot C, Kramvis A, Miller V, Ninburg M, Pénicaud C, Protzer U, Razavi H, Thomas LA, Wallace J, Cowie BC.

Nat Rev Gastroenterol Hepatol. 2018 Sep;15(9):517-518. doi: 10.1038/s41575-018-0041-6. No abstract available.

PMID:
30050162
36.

Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.

Leeksma AC, Taylor J, Wu B, Gardner JR, He J, Nahas M, Gonen M, Alemayehu WG, Te Raa D, Walther T, Hüllein J, Dietrich S, Claus R, de Boer F, de Heer K, Dubois J, Dampmann M, Dürig J, van Oers MHJ, Geisler CH, Eldering E, Levine RL, Miller V, Mughal T, Lamanna N, Frattini MG, Heaney ML, Zelenetz A, Zenz T, Abdel-Wahab O, Kater AP.

Leukemia. 2018 Jul 23. doi: 10.1038/s41375-018-0215-9. [Epub ahead of print]

PMID:
30038380
37.

Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.

Necchi A, Bratslavsky G, Corona RJ, Chung JH, Millis SZ, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Severson E, Daniel S, Killian JK, Ali SM, Schrock AB, Reddy P, Miller VA, Welsh A, Gay LM, Ross JS.

Eur Urol Focus. 2018 Jul 16. pii: S2405-4569(18)30179-2. doi: 10.1016/j.euf.2018.07.013. [Epub ahead of print]

PMID:
30025711
38.

Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study.

Miller VM, Hodis HN, Lahr BD, Bailey KR, Jayachandran M.

Menopause. 2018 Jul 16. doi: 10.1097/GME.0000000000001167. [Epub ahead of print]

PMID:
30020254
39.

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC.

Riess JW, Gandara DR, Frampton GM, Madison R, Peled N, Bufill JA, Dy GK, Ou SI, Stephens PJ, McPherson JD, Lara PN Jr, Burich RA, Ross JS, Miller VA, Ali SM, Mack PC, Schrock AB.

J Thorac Oncol. 2018 Oct;13(10):1560-1568. doi: 10.1016/j.jtho.2018.06.019. Epub 2018 Jul 5.

PMID:
29981927
40.

Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA.

Clark TA, Chung JH, Kennedy M, Hughes JD, Chennagiri N, Lieber DS, Fendler B, Young L, Zhao M, Coyne M, Breese V, Young G, Donahue A, Pavlick D, Tsiros A, Brennan T, Zhong S, Mughal T, Bailey M, He J, Roels S, Frampton GM, Spoerke JM, Gendreau S, Lackner M, Schleifman E, Peters E, Ross JS, Ali SM, Miller VA, Gregg JP, Stephens PJ, Welsh A, Otto GA, Lipson D.

J Mol Diagn. 2018 Sep;20(5):686-702. doi: 10.1016/j.jmoldx.2018.05.004. Epub 2018 Jun 22.

41.

Whole exome sequencing in the rat.

Foley JF, Phadke DP, Hardy O, Hardy S, Miller V, Madan A, Howard K, Kruse K, Lord C, Ramaiahgari S, Solomon GG, Shah RR, Pandiri AR, Herbert RA, Sills RC, Merrick BA.

BMC Genomics. 2018 Jun 20;19(1):487. doi: 10.1186/s12864-018-4858-8.

42.

Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors.

Goodman AM, Piccioni D, Kato S, Boichard A, Wang HY, Frampton G, Lippman SM, Connelly C, Fabrizio D, Miller V, Sicklick JK, Kurzrock R.

JAMA Oncol. 2018 Sep 1;4(9):1237-1244. doi: 10.1001/jamaoncol.2018.1701.

43.

Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.

Tarlock K, Zhong S, He Y, Ries R, Severson E, Bailey M, Morley S, Balasubramanian S, Erlich R, Lipson D, Otto GA, Vergillo JA, Kolb EA, Ross JS, Mughal T, Stephens PJ, Miller V, Meshinchi S, He J.

Oncotarget. 2018 May 29;9(41):26417-26430. doi: 10.18632/oncotarget.25443. eCollection 2018 May 29.

44.

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.

Intlekofer AM, Joffe E, Batlevi CL, Hilden P, He J, Seshan VE, Zelenetz AD, Palomba ML, Moskowitz CH, Portlock C, Straus DJ, Noy A, Horwitz SM, Gerecitano JF, Moskowitz A, Hamlin P, Matasar MJ, Kumar A, van den Brink MR, Knapp KM, Pichardo JD, Nahas MK, Trabucco SE, Mughal T, Copeland AR, Papaemmanuil E, Moarii M, Levine RL, Dogan A, Miller VA, Younes A.

Blood Cancer J. 2018 Jun 12;8(6):60. doi: 10.1038/s41408-018-0089-0.

45.

Adolescents Spending Time Alone With Pediatricians During Routine Visits: Perspectives of Parents in a Primary Care Clinic.

Miller VA, Friedrich E, García-España JF, Mirman JH, Ford CA.

J Adolesc Health. 2018 Sep;63(3):280-285. doi: 10.1016/j.jadohealth.2018.01.014. Epub 2018 Jun 7.

PMID:
29887486
46.

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.

Schrock AB, Zhu VW, Hsieh WS, Madison R, Creelan B, Silberberg J, Costin D, Bharne A, Bonta I, Bosemani T, Nikolinakos P, Ross JS, Miller VA, Ali SM, Klempner SJ, Ou SI.

J Thorac Oncol. 2018 Sep;13(9):1312-1323. doi: 10.1016/j.jtho.2018.05.027. Epub 2018 Jun 5.

47.

Sex Steroids and Incident Cardiovascular Disease in Post-Menopausal Women: New Perspective on an Old Controversy.

Miller VM, Mankad R.

J Am Coll Cardiol. 2018 Jun 5;71(22):2567-2569. doi: 10.1016/j.jacc.2018.01.084. No abstract available.

PMID:
29852979
48.

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden.

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M.

Lung Cancer (Auckl). 2018 May 18;9:45-47. doi: 10.2147/LCTT.S161738. eCollection 2018.

49.

Decision-Making Involvement and Prediction of Adherence in Youth With Type 1 Diabetes: A Cohort Sequential Study.

Miller VA, Jawad AF.

J Pediatr Psychol. 2018 May 17. doi: 10.1093/jpepsy/jsy032. [Epub ahead of print]

PMID:
29788441
50.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

PMID:
29773717

Supplemental Content

Loading ...
Support Center